Arrhythmias Flashcards
What are the 2 types of ventricular arrhythmias?
Ventricular premature beat (VPB) - mild, normally not treated
Ventricular fibrillation (VF) - most severe, rapidly lethal, must be prevented
What are the 2 causes if a heartbeat originates somewhere?
Abnormal pacemaking or the failure of conduction to stop at the end of the heartbeat (re-entry)
How can re-entry happen?
Re-entry is caused by localised slow conduction due to ischaemia induced depolarisation = causes the wave front to be ragged and splitting into 2 = circles around and re-enters the original pathway
What are the 2 (out of 4) main classes of anti-arrhythmic drugs that were discussed?
Class 1 (Na+ channel blockers) and Class 3 (b1 antagonists)
What are the 2 main ways of blocking conduction of the re-entry wave? How do they work?
Direct - by targeting the ischaemic conduction region
Indirect - by delaying repolarisation in the pathway to prolong the refractory period
What is the problem with direct targeting of re-entry?
Drugs must selectively target channels in the damaged region to block local condution. However, most aren’t selective enough and can slow the conduction in surrounding healthy tissue.
What is the mechanism of action of lidocaine? Why is not widely used anymore?
Lidocaine is a Class 1 anti-arrhythmic drug that selectively blocks Na+ channels in ischaemic tissue. However, it can cause nerve effects such as paraesthesia and convulsions.
How do Class 3 anti-arrhythmics indirectly block the re-entry? What should this effect be selective for and why?
Block the K+ channels delayed repolarisation = prolonged refractory period = indirect block of Na channels and conduction
This should be selective for abnormal or fast rhythms to block re-entry during tachyarrhythmia
What is amiodarone? What are its problems?
Class 3 anti-arrhythmic used for VF prophylaxis
You can only take amiodarone for 3 years, it can cause thyroid dysfunction and corneal opacities
What is D-sotalol? What are its problems?
Second generation of Class 3 anti-arrhythmics, high potency and selectivity for K+ channels
Increased mortality in patients